A detailed history of Measured Wealth Private Client Group, LLC transactions in Bio Techne Corp stock. As of the latest transaction made, Measured Wealth Private Client Group, LLC holds 579 shares of TECH stock, worth $34,381. This represents 0.01% of its overall portfolio holdings.

Number of Shares
579
Holding current value
$34,381
% of portfolio
0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

BUY
$49.87 - $58.78 $28,874 - $34,033
579 New
579 $32,000

Others Institutions Holding TECH

About BIO-TECHNE Corp


  • Ticker TECH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,222,600
  • Market Cap $2.33B
  • Description
  • Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protein Sciences segment develops and manufactures bi...
More about TECH
Track This Portfolio

Track Measured Wealth Private Client Group, LLC Portfolio

Follow Measured Wealth Private Client Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Measured Wealth Private Client Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Measured Wealth Private Client Group, LLC with notifications on news.